The Global Prothrombin Complex Concentrate Market. CSL Limited held the highest market share due to emphasis on realigning its diversification strategy to improve the accessibility of its key PCC brands Kcentra and Beriplex.
The Global Prothrombin Complex Concentrates Market is probably going to pick up footing because of the huge drop sought after for its partner new solidified plasma (FFP). Fortune Business Insights has distributed a report, titled ‘Prothrombin Complex Concentrate Market Size, Share and Global Trend by Product Type (3-factor PCC, 4-factor PCC), Application (Congenital and Acquired Coagulation Factor insufficiency), End User (Hospitals, Ambulatory Surgical Centres) and Geography Forecast till 2025. In this report, Fortune Business Insights has anticipated that this market, which was esteemed at US$536.3 MN in 2017, reach US$ 1,076.5 MN and in doing as such, it will show a CAGR of displaying a CAGR of 9.1%.
Request Sample Copy at https://www.fortunebusinessinsights.com/enquiry/sample/prothrombin-complex-concentrate-market-100102
Clinical studies have proven that fresh frozen plasma needed much longer infusion time, as compared to prothrombin complex concentrate (PCC). Besides infusion time, PCC possesses some other advantages over FFP. Some notable properties that have led to PCC’s increasing adoption are its ability to reconstitute in a short span. Furthermore, PCC is available easily due to its lack of blood group specificity. In addition to the aforementioned factors, a better safety profile of PCC has influenced users to prefer them over fresh frozen plasma.
Leading Companies Are Focusing On Setting Up Plasma Collection Centres
As companies are realizing the clinical advantages of PCC over fresh frozen plasma, they are now focusing on research and development of PCC. It is seen that there is an emphasis on stocking up plasma from blood that is required in PCC. To ensure that these needs are sufficed, leading companies such as Grifols SA and Octapharma are putting in increased efforts towards setting up plasma collection centers across several countries around the world.
Kcentra Has Changed the Face of PCC, Globally
Ever since Kcentra was approved by the FDA, it has been adopted by many healthcare professionals worldwide. Kcentra has proven efficient in restoring blood coagulation, as it is packed with certain factors that help replenish various clotting factors. Kcentra played a major role in treatments for patients who are undergoing warfarin therapy. Warfarin may lead to severe and acute blood loss and to minimize such losses and restoring coagulation factors, Kcentra has been proved beneficial. Therefore, the use of PCC in warfarin-induced bleeding is leading to increased adoption which in turn has boosted the global market.
Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/prothrombin-complex-concentrate-market-100102
Increasing Government Initiatives and Funding to Boost the Global Market
Recent updates in policies regarding usage approval have boded well for prothrombin complex concentrates. There has been a relaxation in the usage of PCC in treating bleeding disorders, globally. This has encouraged research analysts and related personnel to conduct more clinical trials and propose newer usage concepts to the regulatory authorities. Moreover, increasing government funding promoting the use of PCC in surgical procedures is boosting the global market. Proven clinical efficiency of PCC has encouraged governments across the world to promote the use of PCC for treating unwanted bleeding in surgical procedures. Furthermore, few alternatives are available to treat bleeding and the existing alternatives do not come close to the standards set by PCC. This, in turn, has led to an increase in demand for PCC and subsequently boosted the global PCC market.
TOC Followed By:
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
- Executive Summary
- Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
- Key Insights
4.1. Prevalence of Coagulation Factor Deficiency – For Key Countries
4.2. Recent Industry Developments – Partnerships, Mergers & Acquisitions
4.3. Regulatory Scenario – For Key Countries
4.4. Analysis in Relation to Alternatives to PCC
4.5. Global PCC Market: Reimbursement Scenario & Key Industry Trends
Speak To Analyst at https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/prothrombin-complex-concentrate-market-100102
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245